Table 1.

Altered immunometabolism, significance, and potential treatment for glycolysis, FAO, and OXPHOS. This Table was adapted from the article by Wilson, C.S. and Moore, D.J. [9].

Altered Immunometabolism	Significance	Potential Treatment
Enhanced lipid uptake due to the upregulation of CD36/fatty acid transport protein	Activation of inflammasomes	Etomoxir CD36 blocker	A
Enhanced glucose uptake	Enhanced glycolysis in naive B cells and altered glycosylation and function on immunoglobulin	2DG or Glut1 inhibitors	B
Increase mitochondrial mass and function	Increased inhibition of regulatory phosphatase due to mitochondrial ROS	Metformin	C
ROS resistance	Resistance to metabolic stress	ROS inhibitor	D